Multispecialty Centre for Surgery, Minimally Invasive and Robotic Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.
Division of Thoracic Surgery, Department of Surgical, Medical, Molecular, Pathology and Critical Care, University Hospital of Pisa, Pisa, Italy.
Int J Colorectal Dis. 2020 Jan;35(1):9-18. doi: 10.1007/s00384-019-03386-z. Epub 2019 Nov 4.
Pulmonary metastasectomy is considered a potentially curative treatment for selected patients with metastatic colorectal cancer (CRC). Several prognostic factors have been analysed, but to date, it is still not well defined which is the optimal resection margin during lung metastasectomy (LM). This study analyses the long-term results and prognostic factors after LM in CRC patients with particular attention to the resection margins. Primary endpoint of this study is to assess the correlation between resection margins and long-term outcomes.
Observational cohort study on all proven cases of CRC lung metastases (2000-2016) resected with curative intent in a single centre.
The series included 210 consecutive patients (M/F 133/77) with a mean age of 65.4 (± 9.96) years, 75% (159/210) of them with a solitary metastasis. Mean size of metastasis was 2.57 cm (± 1.45). One hundred sixty-eight patients underwent wedge resections (80%) and lymphadenectomy was carried out in 90 cases (42.9%). With a mean follow-up of 56 months (range 5-192), we observed a 1-, 3- and 5-year overall survival (OS) of 95%, 74% and 54%, respectively. The patients were divided into three groups according to the resection margin distance from the tumour: (a) ≥ 2 cm (145 cases); (b) < 2, ≥ 1 cm (37 cases); and (c) < 1 cm (12 cases). The OS was significantly different between the three groups (p = 0,020); univariate and multivariate analyses showed that a narrow resection margin was an independent prognostic factor of worse survival (p = 0.006 and HR 3.4 p = 0.009).
Long-term survival of patients after LM is strongly associated with a greater distance between the lesion and the resection margin.
肺转移瘤切除术被认为是一种有潜在治愈可能的治疗方法,适用于特定的转移性结直肠癌(CRC)患者。已经分析了几种预后因素,但迄今为止,在肺转移瘤切除术(LM)中仍未明确最佳的切除边界。本研究特别关注切除边界,分析 CRC 患者 LM 后的长期结果和预后因素。本研究的主要终点是评估切除边界与长期结果之间的相关性。
对单中心 2000 年至 2016 年间行根治性切除术的所有 CRC 肺转移瘤(经证实)的病例进行观察性队列研究。
该系列纳入了 210 例连续的 CRC 肺转移患者(男/女 133/77),平均年龄为 65.4(±9.96)岁,75%(159/210)为单发转移。转移灶的平均大小为 2.57cm(±1.45)。168 例患者行楔形切除术(80%),90 例(42.9%)行淋巴结清扫术。平均随访 56 个月(范围 5-192),观察到 1 年、3 年和 5 年总生存率(OS)分别为 95%、74%和 54%。根据肿瘤切除边界距离,患者分为三组:(a)≥2cm(145 例);(b)<2cm,≥1cm(37 例);(c)<1cm(12 例)。三组间 OS 差异有统计学意义(p=0.020);单因素和多因素分析表明,窄切缘是生存较差的独立预后因素(p=0.006,HR 3.4,p=0.009)。
LM 后患者的长期生存与病变与切除边界之间的距离密切相关。